Mallory Morales
Finanzdirektor/CFO bei IMMUNEERING CORPORATION
Vermögen: 11 838 $ am 30.04.2024
Profil
Mallory Morales is currently the Treasurer, Chief Financial & Accounting Officer at Immuneering Corp.
Prior to this, Ms. Morales worked as the Director & Assistant Controller at Immunomedics, Inc. from 2018 to 2020.
Before that, Ms. Morales held the position of Director-Finance & Global Brand Controller at L'Oréal SA from 2014 to 2018.
Ms. Morales also worked as a Strategic Finance Business Partner at Gilead Sciences, Inc. from 2020 to 2021.
Ms. Morales obtained an undergraduate degree from the State University of New York at Albany.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.03.2024 | 8 278 ( 0,03% ) | 11 838 $ | 30.04.2024 |
Aktive Positionen von Mallory Morales
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNEERING CORPORATION | Finanzdirektor/CFO | 10.08.2022 |
Ehemalige bekannte Positionen von Mallory Morales
| Unternehmen | Position | Ende |
|---|---|---|
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01.05.2021 |
| IMMUNOMEDICS, INC. | Direktor/Vorstandsmitglied | 01.10.2020 |
| L'ORÉAL | Finanzdirektor/CFO | 01.04.2018 |
Ausbildung von Mallory Morales
| State University of New York at Albany | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| L'ORÉAL | Consumer Non-Durables |
| Private Unternehmen | 1 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
